Short communicationJournal of Young PharmacistsVol. 9 | Issue 2 | 2017 | pp. 296–298Open access
In vivo Study of Tetraprenyltoluquinone, An Anticancer Compounds from Garcinia cowa Roxb
- 1*,
- 2,
- 3,
- 4,
- 1
- 1 Faculty of Pharmacy, Andalas University, Kampus Limau Manis, Padang, West Sumatra, INDONESIA.
- 2 CARIF (Cancer Research Institute Foundation) , MALAYSIA.
- 3 Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 43400 UPM, Serdang, Selangor, MALAYSIA.
- 4 Laboratory of Natural Products, Institut of Bioscience, Universiti Putra Malaysia, 43400 UPM, Serdang, Selangor, MALAYSIA.
Published in Journal of Young Pharmacists
Correspondence: Fatma Sri Wahyuni
Faculty of Pharmacy, Andalas University, Kampus Limau Manis, Padang, West Sumatra, INDONESIA.
Email: fatmasriwahyuni@gmail.com
Copyright: © 2017 Manuscript Technomedia. This is an open access article.
- Published:
- Apr 23, 2017
- Received:
- Nov 7, 2016
- Accepted:
- Dec 28, 2016
How to cite
Wahyuni, F. S., Hui, L. S., Stanslas, J., Lajis, N. H., & d, D. (2017). In vivo Study of Tetraprenyltoluquinone, An Anticancer Compounds from Garcinia cowa Roxb. Journal of Young Pharmacists, 9(2), 296–298. https://doi.org/10.5530/jyp.2017.9.58
Abstract
Objective: To investigate the in vivo antitumor effect of TPTQ against H-460 lung cancer cell lines in nude mice. Materials and Methods: Female nude mice bearing H-460 tumor at size approximately 5 mm in diameter were treated with a single intraperitoneal dose 800 mg/kg of TPTQ. The vehicle treated (10% tween 80) animals were used as control group. The tumor size and mice body weight were measured for 14 days. Results: Single treatment of 800 mg/kg of TPTQ displayed moderate antitumor activity against H-460 tumor xenografts as compared with vehicle-treated control. The mean time to reach RTV of 4 for vehicle-treated control group was 4.5 days whereas for TPTQ-treated (800 mg/kg) group was 9.5 days. Conclusion: The results showed that TPTQ slowed the tumor growth by 5 days. Thus, TPTQ may be considered as a promising compound in cancer chemotherapy.
Keywords
Subject
Article metadata
| Title | In vivo Study of Tetraprenyltoluquinone, An Anticancer Compounds from Garcinia cowa Roxb |
|---|---|
| Authors | Fatma Sri Wahyuni; Lim Siang Hui; Johnson Stanslas; Nordin Hj Lajis; Dachriyanus d |
| Affiliations | Faculty of Pharmacy, Andalas University, Kampus Limau Manis, Padang, West Sumatra, INDONESIA.; CARIF (Cancer Research Institute Foundation) , MALAYSIA.; Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 43400 UPM, Serdang, Selangor, MALAYSIA.; Laboratory of Natural Products, Institut of Bioscience, Universiti Putra Malaysia, 43400 UPM, Serdang, Selangor, MALAYSIA. |
| Corresponding author | fatmasriwahyuni@gmail.com |
| Journal | Journal of Young Pharmacists |
| Volume / Issue | Vol. 9, Issue 2 (2017) |
Also in this issue
- Comparison of Adverse Effects of Newer Atypical Antipsychotics: An Evidence Based Reviewpp. 140–144
- Highly Cited Publications Output by India in Clinical Pharmacology during 2000-14: A Scientometric Assessmentpp. 145–157
- Design, Synthesis and Characterization of Benzothiazole Analogues as Promising Pharmacological Agentspp. 158–161
- 3D QSAR Studies on Some 5-(1H-Indol-5-yl)-1, 3, 4-Thiadiazol-2 Amines as Potential PIM-1 Inhibitorspp. 162–167
- In-Silico Screening of Flavonoids Targeted for Death Receptors in Cancer by Using Hex Molecular Dockingpp. 168–171
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026